查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631243

C型肝炎病毒(HCV)检验的全球市场 - 全球产业分析，规模，占有率，成长，趋势，预测(2032年)

Hepatitis C virus (HCV) Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 190 Pages | 商品交期: 2-5个工作天内

价格
简介目录

随着人们认识的提高、诊断技术的进步和积极的医疗保健举措，全球丙型肝炎病毒 (HCV) 检测市场规模正在持续增长。预计到 2025 年市场规模将达到 8.94 亿美元，到 2032 年预计将成长至 13.267 亿美元，复合年增长率为 5.80%。

市场概况HCV 检测在识别和管理全球健康问题丙型肝炎感染方面发挥关键作用。此过程可检测 HCV RNA 或抗体，从而实现早期介入和治疗。先进的诊断技术，包括核酸和酵素免疫测定，可以进行准确、全面的检测，是减少肝臟相关併发症的公共卫生策略的基石。

受丙型肝炎盛行率上升、诊断技术的进步和积极的医疗对策的推动，HCV 检测市场预计将经历显着增长。领先公司的策略性举措和对早期检测的关注预计将为全球管理 HCV 感染提供有效的解决方案，从而推动市场发展。随着不断进步，预计该市场将在全球医疗保健中发挥重要作用。

本报告提供全球C型肝炎病毒(HCV)检验市场相关调查，提供市场概要，以及技术，各检验类型，各终端用户，及各地区趋势，及市场参与市场企业的竞争趋势等资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场定义和市场区隔
  • 市场动态
  • 价值链分析
  • 波特的五力分析
  • COVID-19影响分析
  • 乌克兰·俄罗斯纠纷的影响
  • 经济概要
  • 大环境分析

第3章 2024年的价格分析

第4章 全球C型肝炎病毒(HCV)检验市场预测，2019年～2032年

  • 全球C型肝炎病毒(HCV)检验市场预测，技术，金额(10亿美元)，数量(事)，2019年～2032年
  • 全球C型肝炎病毒(HCV)检验市场预测，各检验类型，价值(10亿美元)，2019年～2032年
  • 全球C型肝炎病毒(HCV)检验市场预测，各终端用户，价值(10亿美元)，2019年～2032年
  • 全球C型肝炎病毒(HCV)检验市场预测，各地区，价值(10亿美元)，数量(事)，2019年～2032年

第5章 北美的C型肝炎病毒(HCV)检验市场预测，2019年～2032年

第6章 欧洲的C型肝炎病毒(HCV)检验市场预测，2019年～2032年

第7章 亚太地区的C型肝炎病毒(HCV)检验市场预测，2019年～2032年

第8章 南美的C型肝炎病毒(HCV)检验市场预测，2019年～2032年

第9章 中东·非洲的C型肝炎病毒(HCV)检验市场预测，2019年～2032年

第10章 竞争情形

  • 企业市场占有率分析，2024年
  • 竞争仪表板
  • 企业简介
    • OraSure Technologies, Inc.
    • Abbott Laboratories Inc.
    • Siemens Healthcare GmbH
    • Bio Rad Laboratories Inc.
    • Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
    • Bayer AG
    • QIAGEN N.V.
    • Thermo Fisher Scientific Inc.
    • BioGenex
    • AccuQuick,
    • Roche Diagnostics (F. Hoffman-La Roche Ltd.)
    • STD Rapid Test Kits

第11章 附录

简介目录

The global Hepatitis C Virus (HCV) testing market is witnessing consistent growth, fueled by rising awareness, advancements in diagnostic technologies, and active healthcare initiatives. By 2025, the market is expected to reach 894 million, with projections indicating a rise to 1,326.7 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.80%.

Market Overview HCV testing plays a vital role in identifying and managing Hepatitis C infections, a major global health concern. The process involves detecting HCV RNA or antibodies, enabling early intervention and treatment. Advanced diagnostic techniques, including nucleic acid and enzyme immunoassays, ensure accurate and comprehensive testing, making it a cornerstone in public health strategies to reduce liver-related complications.

The HCV testing market is poised for significant growth, driven by the rising prevalence of Hepatitis C, advancements in diagnostic technologies, and proactive healthcare measures. Strategic actions by major players and a focus on early detection are expected to drive the market forward, providing effective solutions for managing HCV infections globally. With continuous advancements, the market is positioned to play a critical role in global healthcare.

Key Market Drivers

  • 1. Increasing Hepatitis C Prevalence: The global rise in Hepatitis C infections has heightened the demand for accurate diagnostic methods. High-risk groups, such as individuals exposed to unsafe medical practices and intravenous drug users, underscore the importance of effective testing solutions.
  • 2. Technological Innovations: Breakthroughs in diagnostic technology, such as polymerase chain reaction (PCR) and advanced immunoassays, have improved the sensitivity and accuracy of HCV testing, encouraging wider adoption.
  • 3. Government and Awareness Campaigns: Efforts by governments and healthcare organizations to combat infectious diseases have boosted the uptake of HCV testing. Awareness programs highlighting early detection and treatment further drive market growth.

Opportunities for Growth The shift towards preventive healthcare and routine screenings creates lucrative opportunities for market participants. Increased investment in public health campaigns has made HCV testing a standard part of health evaluations, expanding its accessibility. Additionally, the adoption of point-of-care testing (POCT) technologies offers faster and more convenient diagnostic options in various healthcare settings.

Regional Insights

  • 1. Asia Pacific: This region holds the largest market share, driven by a large population base and significant prevalence of Hepatitis C infections. Enhanced healthcare infrastructure and supportive government initiatives further fuel market growth.
  • 2. Middle East & Africa: Expected to grow the fastest, this region faces unique infectious disease challenges. Investments in healthcare infrastructure and early diagnostic initiatives are fostering market expansion.
  • 3. North America and Europe: These regions exhibit steady growth due to advanced healthcare systems, widespread adoption of diagnostic technologies, and heightened public awareness.

Leading Market Players Key companies shaping the HCV testing market include:

  • Abbott Laboratories Inc.
  • Siemens Healthcare GmbH
  • Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
  • Bio-Rad Laboratories Inc.
  • OraSure Technologies, Inc.
  • Bayer AG
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Ortho Clinical Diagnostics Inc. (Johnson & Johnson)

These industry leaders employ strategies such as technological advancements, strategic partnerships, and awareness campaigns to strengthen their market positions. For instance, Abbott Laboratories' ARCHITECT anti-HCV immunoassay and Roche Diagnostics' PCR-based assays highlight their dedication to providing precise and reliable diagnostic solutions.

Market Segmentation

1. By Technique:

    Immunoassays-based Hepatitis C Virus Testing Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing Other Testing Techniques

2. By Test Type:

    HCV Antibody Testing HCV Viral Load Testing HCV Genotyping Testing

3. By End User:

    Hospitals Diagnostic Centers Blood Donation Centers

4. By Region:

    North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Hepatitis C virus (HCV) Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume (Units), 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2024

  • 3.1. Global Average Price Analysis, by Technique, US$ Per Unit, 2019 - 2023
  • 3.2. Prominent Factor Affecting Hepatitis C virus (HCV) Testing Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 4.1. Global Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 4.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 4.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 4.2. Global Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. HCV Antibody Testing
      • 4.2.1.2. HCV Viral Load Testing
      • 4.2.1.3. HCV Genotyping Testing
  • 4.3. Global Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Diagnostic Centers
      • 4.3.1.3. Blood Donation Centers
  • 4.4. Global Hepatitis C virus (HCV) Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 5.1. North America Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 5.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 5.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 5.2. North America Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. HCV Antibody Testing
      • 5.2.1.2. HCV Viral Load Testing
      • 5.2.1.3. HCV Genotyping Testing
  • 5.3. North America Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Diagnostic Centers
      • 5.3.1.3. Blood Donation Centers
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. North America Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.2. U.S. Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. U.S. Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. Canada Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.5. Canada Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. Canada Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 6.1. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 6.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 6.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 6.2. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. HCV Antibody Testing
      • 6.2.1.2. HCV Viral Load Testing
      • 6.2.1.3. HCV Genotyping Testing
  • 6.3. Europe Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Diagnostic Centers
      • 6.3.1.3. Blood Donation Centers
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.2. Germany Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. Germany Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. U.K. Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.5. U.K. Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. U.K. Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. France Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.8. France Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. France Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. Italy Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.11. Italy Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. Italy Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Turkey Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.14. Turkey Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Turkey Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Russia Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.17. Russia Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Russia Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.19. Rest of Europe Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.20. Rest of Europe Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.21. Rest of Europe Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 7.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 7.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 7.2. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. HCV Antibody Testing
      • 7.2.1.2. HCV Viral Load Testing
      • 7.2.1.3. HCV Genotyping Testing
  • 7.3. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Diagnostic Centers
      • 7.3.1.3. Blood Donation Centers
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.2. China Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. China Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Japan Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.5. Japan Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Japan Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. South Korea Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.8. South Korea Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. South Korea Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. India Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.11. India Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. India Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.13. Southeast Asia Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.14. Southeast Asia Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.15. Southeast Asia Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.16. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.17. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.18. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 8.1. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 8.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 8.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 8.2. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. HCV Antibody Testing
      • 8.2.1.2. HCV Viral Load Testing
      • 8.2.1.3. HCV Genotyping Testing
  • 8.3. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Diagnostic Centers
      • 8.3.1.3. Blood Donation Centers
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.2. Brazil Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. Brazil Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. Mexico Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.5. Mexico Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. Mexico Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Argentina Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.8. Argentina Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Argentina Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Rest of Latin America Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.11. Rest of Latin America Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Rest of Latin Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 9.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 9.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 9.2. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. HCV Antibody Testing
      • 9.2.1.2. HCV Viral Load Testing
      • 9.2.1.3. HCV Genotyping Testing
  • 9.3. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Diagnostic Centers
      • 9.3.1.3. Blood Donation Centers
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.2. GCC Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.3. GCC Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.4. South Africa Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.5. South Africa Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.6. South Africa Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.7. Egypt Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.8. Egypt Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.9. Egypt Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.10. Nigeria Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.11. Nigeria Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.12. Nigeria Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.13. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.14. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.15. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Company Market Share Analysis, 2024
  • 10.2. Competitive Dashboard
  • 10.3. Company Profiles
    • 10.3.1. OraSure Technologies, Inc.
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Technique Portfolio
      • 10.3.1.3. Financial Overview
      • 10.3.1.4. Business Strategies and Development
    • 10.3.2. Abbott Laboratories Inc.
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Technique Portfolio
      • 10.3.2.3. Financial Overview
      • 10.3.2.4. Business Strategies and Development
    • 10.3.3. Siemens Healthcare GmbH
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Technique Portfolio
      • 10.3.3.3. Financial Overview
      • 10.3.3.4. Business Strategies and Development
    • 10.3.4. Bio Rad Laboratories Inc.
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Technique Portfolio
      • 10.3.4.3. Financial Overview
      • 10.3.4.4. Business Strategies and Development
    • 10.3.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Technique Portfolio
      • 10.3.5.3. Financial Overview
      • 10.3.5.4. Business Strategies and Development
    • 10.3.6. Bayer AG
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Technique Portfolio
      • 10.3.6.3. Financial Overview
      • 10.3.6.4. Business Strategies and Development
    • 10.3.7. QIAGEN N.V.
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Technique Portfolio
      • 10.3.7.3. Financial Overview
      • 10.3.7.4. Business Strategies and Development
    • 10.3.8. Thermo Fisher Scientific Inc.
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Technique Portfolio
      • 10.3.8.3. Financial Overview
      • 10.3.8.4. Business Strategies and Development
    • 10.3.9. BioGenex
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Technique Portfolio
      • 10.3.9.3. Financial Overview
      • 10.3.9.4. Business Strategies and Development
    • 10.3.10. AccuQuick,
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Technique Portfolio
      • 10.3.10.3. Financial Overview
      • 10.3.10.4. Business Strategies and Development
    • 10.3.11. Roche Diagnostics (F. Hoffman-La Roche Ltd.)
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Technique Portfolio
      • 10.3.11.3. Financial Overview
      • 10.3.11.4. Business Strategies and Development
    • 10.3.12. STD Rapid Test Kits
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Technique Portfolio
      • 10.3.12.3. Financial Overview
      • 10.3.12.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations